Externally-applied medicine for treating leucoderma

Abstract

The invention discloses an externally-applied medicine for treating leucoderma. The externally-applied medicine is prepared from, by weight, 21-28 parts of herba portulacae, 20-25 parts of common cnidium fruits, 22-27 parts of sanguisorba officinalis, 14-20 parts of periostracum cicada, 15-20 parts of beautiful sweetgum fruits, 13-18 parts of radix angelicae pubescentis, 14-19 parts of rhizoma galangae, 5-10 parts of fructus psoraleae, 6-10 parts of fleece flower roots, 6-12 parts of yerbadetajo herbs, 7-13 parts of raspberries, 5-12 parts of flatstem milkvetch seeds, 8-13 parts of cortex pseudolaricis and 2-3 parts of the roots of bidentate achyranthes. According to the externally-applied medicine for treating leucoderma, the whole effective rate is 100%, the treating time is only three treatment courses, namely 21 days, and the treating effect is good.

Description

technical field [0001] The invention relates to a medicine for external use, in particular to a medicine for external use for treating vitiligo. It belongs to the field of medical technology. Background technique [0002] Vitiligo is a common acquired localized or generalized skin depigmentation disease, which is caused by the loss of skin melanocyte function, but the mechanism is still unclear. The disease can occur in various parts of the body, and is common in the back of the fingers, wrists, forearms, face, neck, and around the genitals. It can also occur in the genitals of women, mostly young women. [0003] There is no significant difference in gender, and all age groups can develop the disease, but it is more common in adolescents. The skin lesions are depigmented spots, usually milky white or light pink, with smooth surface and no rash. The boundary of the leukoplakia is clear, the pigment at the edge is increased compared with normal skin, and the hair in the leu...

AI Technical Summary

Problems solved by technology

Modern medicine believes that there are several possibilities: abnormal nerve cell function produces substances that are toxic to melanocytes, the body's immune system is dysfunctional to attack and destroy melanocytes or the defects of melanocytes themselves, some It is a by-product that is toxic to itself. In addition, patients with vitiligo may have certain genetic defects that make melanocytes easily destroyed, resulting in the occurrence of vitiligo

At present, there are many methods and drugs for treating vitiligo on the market, and the effects are different. Usually, heavy metal or hormone drugs are used for systemic treatment. Because they contain hormone or heavy metal components, there are many allergic patients, and long-term use can easily lead to skin aging and fibrosis. The efficacy is not satisfactory

In addition, the existing drugs generally have the problem that the effect of the drug cannot be sustained, and rebound occurs after stopping the drug, so it must be taken continuously for a long time

Oral drugs will also burden the liver and kidneys of patients, and there are safety problems

Images